Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback